FDA Panel Wants Restrictions On Anti Anemia Drugs (Medical News Today)
The US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee decided yesterday to recommend restrictions on the use of anti anemia drugs to treat patients with certain types of cancer.

Calando Files IND For SiRNA Nanoparticle Therapeutic In Oncology (Medical News Today)
Calando Pharmaceuticals, a leading siRNA therapeutics company, announced that the company has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) to initiate a Phase I clinical trial using their lead anti-cancer compound, CALAA-01.